Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 12:54 AM
Study NCT ID:
NCT01805960
Status:
TERMINATED
Last Update Posted:
2017-02-14
First Post:
2013-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-05
First Submit QC Date:
None
Study First Post Date:
2013-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-13
Last Update Post Date:
2017-02-14
Last Update Post Date Type:
ACTUAL